Allelic variation at the APOE locus impacts survival by both altering the age at onset of AD and by increasing risk of other conditions (hyperlipidaemia, atherosclerosis, cardiovascular disease31–36), and the frequency of APOE-ε4 in the population correspondingly goes down with age11. Here, APOE is linked to hyperlipidemia.